Conversion surgery intervention versus continued systemic therapy in patients with a response after PD-1/PD-L1 inhibitor-based combination therapy for initially unresectable biliary tract cancer: a retrospective cohort study.

MLA

Shanshan Wang, et al. “Conversion Surgery Intervention versus Continued Systemic Therapy in Patients with a Response after PD-1/PD-L1 Inhibitor-Based Combination Therapy for Initially Unresectable Biliary Tract Cancer: A Retrospective Cohort Study.” International Journal of Surgery, vol. 110, no. 8, Aug. 2024, pp. 4608–16. EBSCOhost, https://doi.org/10.1097/JS9.0000000000001540.

APA

Shanshan Wang, Yunchao Wang, Chengpei Zhu, Kai Liu, Jiashuo Chao, Nan Zhang, Mingjian Piao, Xu Yang, Longhao Zhang, Junyu Long, Ziyu Xun, Ting Zhang, Xinting Sang, Xiaobo Yang, & Haitao Zhao. (2024). Conversion surgery intervention versus continued systemic therapy in patients with a response after PD-1/PD-L1 inhibitor-based combination therapy for initially unresectable biliary tract cancer: a retrospective cohort study. International Journal of Surgery, 110(8), 4608–4616. https://doi.org/10.1097/JS9.0000000000001540

Chicago

Shanshan Wang, Yunchao Wang, Chengpei Zhu, Kai Liu, Jiashuo Chao, Nan Zhang, Mingjian Piao, et al. 2024. “Conversion Surgery Intervention versus Continued Systemic Therapy in Patients with a Response after PD-1/PD-L1 Inhibitor-Based Combination Therapy for Initially Unresectable Biliary Tract Cancer: A Retrospective Cohort Study.” International Journal of Surgery 110 (8): 4608–16. doi:10.1097/JS9.0000000000001540.